Valeant, GSK partial-onset seizures drug gets FDA approval
Three controlled clinical trails comprising 1,239 adult patients have established the efficacy of ezogabine as adjunctive therapy in partial onset seizures. The companies plan to introduce the product
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.